Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 173.10
+0.74 (0.43%)
Apr 7, 2026, 4:10 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 11.32 billion as of April 7, 2026. Its market cap has decreased by -34.93% in one year.
Market Cap
11.32B
Enterprise Value
11.38B
Revenue
2.34B
Ranking
n/a
PE Ratio
32.86
Stock Price
173.10
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 11.32B, an increase of 25,524.02%. That is a compound annual growth rate of 20.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 11.32B | -33.59% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 3.32B |
| Anteris Technologies Global | 734.10M |
| PolyNovo | 645.94M |
| Aroa Biosurgery | 200.38M |
| Lumos Diagnostics Holdings | 167.52M |
| EMVision Medical Devices | 148.70M |
| Epiminder | 133.60M |
| SomnoMed | 129.26M |